Clinical TrialsThe potential for a +/- 25%-50% impact to CMPS from the 005 data remains positively inclined heading into the readout.
Market PotentialWith COMP360 on track to become a blockbuster treatment, if approved, the current valuation fails to reflect the full scope of its opportunity across multiple large-market psychiatric disorders.
Strategic CollaborationsCOMPASS is collaborating with HealthPort to optimize access and delivery of COMP360 in underserved communities, potentially expanding its market reach.